Login/Sign Up
Dacoplice 15 mg Tablet 30's
Dacoplice 15 mg Tablet 30's is an anti-cancer medicine used to treat non-small cell lung cancer (NSCLC). It consists of Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of an enzyme (tyrosine kinase) that causes the multiplication of cancerous cells; this prevents the abnormal growth of cancer cells and thus reduces the spread of cancer to other parts of the body.
₹44500*
₹37825*
MRP ₹44500
15% CB
₹6675 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Dacoplice 15 mg Tablet 30's is an anti-cancer medicine used in the treatment of non-small cell lung cancer (NSCLC). It is a common form of lung cancer in which abnormal cells grow in the lung tissues. Dacoplice 15 mg Tablet 30's is used as a first-line therapy in the treatment of metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations.
Dacoplice 15 mg Tablet 30's consists of Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of an enzyme (tyrosine kinase) that causes the multiplication of cancerous cells. This prevents the abnormal growth of cancer cells and thus reduces the further spread to other parts of the body.
Dacoplice 15 mg Tablet 30's may cause certain side effects such as diarrhea, rash, nausea, vomiting, dry skin, mouth sores, nail inflammation, ache, cough, abdominal pain, hair loss, decreased appetite, decreased weight loss, and itching. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Dacoplice 15 mg Tablet 30's should be taken as advised by your doctor. Do not take more than the recommended dose. Your doctor will decide the dose of Dacoplice 15 mg Tablet 30's based on the severity of your condition.
Avoid taking Dacoplice 15 mg Tablet 30's if you are allergic to it or any other components of it. Before taking Dacoplice 15 mg Tablet 30's, inform your doctor if you have/had liver or kidney disease and lung disease other than lung cancer. This medicine is known to cause embryo-fetal toxicity. It is not recommended for use in pregnancy and breastfeeding. Elderly people are more sensitive to medicine, so the dose may have to be adjusted according to their condition.
Dacoplice 15 mg Tablet 30's contains Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. In this way, Dacoplice 15 mg Tablet 30's stops the body's production, spread and growth of cancerous cells.
To treat your condition effectually, continue taking Dacoplice 15 mg Tablet 30's for the period that your doctor has prescribed. Avoid taking Dacoplice 15 mg Tablet 30's if you are allergic to it or any other components present in it. Caution should be exercised if you have/had liver or kidney disease, eye problems, lung disease other than lung cancer, severe cough, and breathing difficulty. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Effective birth control pills should be used for at least 17 days after the last dose of the medicine. Dacoplice 15 mg Tablet 30's may cause severe diarrhea, severe skin conditions, and Interstitial lung disease in some patients. Hence, inform your doctor about your complete medication and medical history before taking Dacoplice 15 mg Tablet 30's. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. Avoid driving and operating machines, as this medicine may cause visual disturbances. This medicine is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interaction: Dacoplice 15 mg Tablet 30's may have interaction with Proton Pump Inhibitors (esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole), Cytochrome-P 450 (CYP2D6) substrate drugs (Codeine, haloperidol, aripiprazole, Nortriptyline)
Drug-Food Interaction: No interaction found.
Dug-Disease Interaction: Tell your doctor if you have liver or kidney disease, vision problems, lung disease, and breathing problems.
Non-Small Cell Lung Cancer (NSCLC): Lung cancer is defined as an Uncontrollable growth of abnormal cells in one or both lungs. These abnormal cells do not carry out normal lung cell functions and do not develop into healthy lung tissue. There are different forms of lung cancer. The most common form of lung cancer is non-small cell lung cancer (NSCLC). It happens when cells that form the lining of the lung start growing uncontrollably. Cancerous cells of the lung spread off and travel through the bloodstream to distant regions of the body and grow. It is mostly seen in persons who smoke. Symptoms may include chest pain, weight loss, hoarseness, and difficulty breathing.
Alcohol
Consult your doctor
It is unknown whether alcohol may interact with Dacoplice 15 mg Tablet 30's. However, as a precautionary measure, it is advisable not to take or limit alcohol. Consult your doctor for more information.
Pregnancy
Unsafe
Dacoplice 15 mg Tablet 30's is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Dacoplice 15 mg Tablet 30's. You should not become pregnant while you are taking Dacoplice 15 mg Tablet 30's and for at least 17 days after your last dose.
Breast Feeding
Unsafe
It is not known whether Dacoplice 15 mg Tablet 30's is present in human milk. However, you should not breastfeed while taking this medicine and, for 17 days after your last dose.
Driving
Unsafe
Dacoplice 15 mg Tablet 30's may cause blurred vision as a side effect. Hence, try to avoid driving, operating machinery, or engaging in any activity that needs clear vision until you are able to see clearly while you are on treatment with Dacoplice 15 mg Tablet 30's.
Liver
Caution
If you have mild to moderate liver problems, inform your doctor before taking Dacoplice 15 mg Tablet 30's. The dose of this medicine has to be adjusted in case you have severe liver disease.
Kidney
Caution
Inform your doctor before receiving Dacoplice 15 mg Tablet 30's if you have a history of kidney diseases. No dose adjustments are required in mild to moderate renal impairment.
Children
Unsafe
Dacoplice 15 mg Tablet 30's is not recommended for children as the safety and effectiveness were not established.
Country of origin
Manufacturer/Marketer address